Eight Years and $83 Million Later, Syqe Medical Releases First Cannabis Inhaler
Teva will market the company's inhalers exclusively in Israel, after signing a marketing and distribution agreement with Syqe in 2016
Tzally Greenberg : 2019-06-20T10:47:14..
Tel Aviv-based cannabis company Syqe Medical Ltd. has unveiled its first cannabis inhaler Wednesday, after having invested $83 million and eight years into its development. The company will begin distributing its product in Israel before expanding to other countries, Syqe’s founder Perry Davidson said in a Wednesday interview with Calcalist.
For daily updates, subscribe to our newsletter by clicking here.The metered-dose inhaler is roughly pocket-sized, and is designed for precise delivery of cannabis and other medicinal plants’ molecules. The inhaler will be priced at NIS 1,950 (approximately $545), the company said in a statement.